Update: Nonprescription Oxybutynin Transdermal System Approved to Treat Overactive Bladder in Women 

Content update for Chapter 49, "Adult Urinary Incontinence and Supplies." Posted March 1, 2013.
Oxytrol for Women, a new nonprescription oxybutynin transdermal system, was recently approved by the Food and Drug Administration (FDA) as the first nonprescription therapy for overactive bladder (OAB) in women 18 years or older with symptoms of urge